These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 24598177)
1. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2014 Mar; 52(3):9-10. PubMed ID: 24598177 [No Abstract] [Full Text] [Related]
2. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):11-2. PubMed ID: 22390784 [No Abstract] [Full Text] [Related]
3. Clip & save: drug chart. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2010 Mar; 48(3):9-10. PubMed ID: 20302260 [No Abstract] [Full Text] [Related]
4. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2019 Mar; 57(3):5-6. PubMed ID: 30835794 [No Abstract] [Full Text] [Related]
5. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2017 Mar; 55(3):17-18. PubMed ID: 28287670 [No Abstract] [Full Text] [Related]
6. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):13-14. PubMed ID: 29505085 [No Abstract] [Full Text] [Related]
7. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2020 Mar; 58(3):5-6. PubMed ID: 32129874 [No Abstract] [Full Text] [Related]
8. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2013 Mar; 51(3):11-2. PubMed ID: 23452016 [No Abstract] [Full Text] [Related]
9. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2021 Mar; 59(3):3-4. PubMed ID: 33647155 [No Abstract] [Full Text] [Related]
10. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2022 Mar; 60(3):5-6. PubMed ID: 35244493 [No Abstract] [Full Text] [Related]
11. Compliance with FDA recommendations for pemoline. Sarkis EH J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383; author reply 383. PubMed ID: 12649623 [No Abstract] [Full Text] [Related]
12. FDA ponders cardiovascular risks of ADHD drugs. Young D Am J Health Syst Pharm; 2006 Mar; 63(6):492-4. PubMed ID: 16522874 [No Abstract] [Full Text] [Related]
13. ADHD drugs and cardiovascular risk. Nissen SE N Engl J Med; 2006 Apr; 354(14):1445-8. PubMed ID: 16549404 [No Abstract] [Full Text] [Related]
14. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny. Strawn MN J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255 [No Abstract] [Full Text] [Related]
15. Quillivant XR--an extended release oral suspension of methylphenidate. Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227 [No Abstract] [Full Text] [Related]
17. Human subjects research. Pediatric study of ADHD drug draws high-level public review. Couzin J Science; 2004 Aug; 305(5687):1088-9. PubMed ID: 15326317 [No Abstract] [Full Text] [Related]
18. ADHD drugs and cardiovascular risk. Rappley MD; Moore JW; Dokken D N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375 [No Abstract] [Full Text] [Related]
19. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment]. 't Jong GW; van den Anker JN Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263 [No Abstract] [Full Text] [Related]
20. Debate over warnings for ADHD stimulants. Child Health Alert; 2006 Apr; 24():1. PubMed ID: 16673500 [No Abstract] [Full Text] [Related] [Next] [New Search]